⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1919337 | 0.74 | — | — | |
| SCHEMBL10692876 | 0.68 | — | — | |
| SCHEMBL4180707 | 0.66 | — | — | |
| SCHEMBL2166445 | 0.65 | — | — | |
| SCHEMBL5866547 | 0.62 | GAA (0.37) | — | |
| SCHEMBL3885172 | 0.62 | — | — | |
| SCHEMBL9458897 | 0.59 | — | — | |
| SCHEMBL7937128 | 0.59 | — | — | |
| Hydrochloric Acid SCHEMBL17593296 | 0.58 | — | — | |
| SCHEMBL250735 | 0.57 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4370109-A1 | SUBEROYLANILIDE HYDROXAMIC ACID (SAHA) DRUGS, CONJUGATES, AND NANOPARTICLES, AND METHODS OF USE THEREOF | University of Maryland, Baltimore (US) | 2024-05-22 | — | — | EP | disclosed |
| EP-4315330-A1 | HALOGENATED MONOMERS AND POLYMERS FOR VOLUME BRAGG GRATINGS | META PLATFORMS TECHNOLOGIES, LLC (US) | 2024-02-07 | — | — | EP | disclosed |
| EP-4308983-A1 | SPATIALLY VARYING DYNAMIC RANGE IN HOLOGRAPHIC GRATINGS | META PLATFORMS TECHNOLOGIES, LLC (US) | 2024-01-24 | — | — | EP | disclosed |
| EP-4309002-A1 | RECORDING A LATENT HOLOGRAPHIC GRATING AND AMPLIFICATION OF ITS DYNAMIC RANGE | META PLATFORMS TECHNOLOGIES, LLC (US) | 2024-01-24 | — | — | EP | disclosed |
| EP-4308666-A1 | MULTIFUNCTIONAL LIQUID CRYSTALLINE PHOTOREACTIVE POLYMERS FOR POLARIZATION HOLOGRAPHY | META PLATFORMS TECHNOLOGIES, LLC (US) | 2024-01-24 | — | — | EP | disclosed |
| WO-2023056264-A1 | NOVEL SUBSTITUTED SULFONYLUREA COMPOUNDS AS INHIBITORS OF INTERLEUKIN-1 ACTIVITY | VIVA STAR BIOSCIENCES (SUZHOU) CO., LTD. (CN) | 2023-04-06 | — | — | WO | disclosed |
| WO-2023023188-A1 | METHODS OF MAKING COMPOSITIONS FROM OLEFIN METATHESIS PHOTOPOLYMERS | PolySpectra, Inc. (US) | 2023-02-23 | — | — | WO | disclosed |
| WO-2023287984-A1 | SUBEROYLANILIDE HYDROXAMIC ACID (SAHA) DRUGS, CONJUGATES, AND NANOPARTICLES, AND METHODS OF USE THEREOF | UNIVERSITY OF MARYLAND, BALTIMORE (US) | 2023-01-19 | — | — | WO | disclosed |
| WO-2022266491-A1 | PROTEOLYSIS TARGETING CHIMERAS AND POLYPHARMACOLOGICAL AGENTS TARGETING BCL-2, AND METHODS OF USE THEREOF | UNIVERSITY OF MARYLAND, BALTIMORE (US) | 2022-12-22 | — | — | WO | disclosed |
| WO-2022120207-A1 | BROAD SPECTRUM ANTIVIRAL COMPOUNDS TARGETING THE SKI COMPLEX | UNIVERSITY OF MARYLAND, BALTIMORE (US) | 2022-06-09 | — | — | WO | disclosed |
| WO-2018175324-A1 | COMPOUNDS AND METHODS FOR REGULATING INSULIN SECRETION | THE BROAD INSTITUTE, INC. (US) | 2018-09-27 | — | — | WO | disclosed |
| WO-2017181012-A1 | CINCHONIUM BETAINE CATALYSTS AND METHODS OF USING SAME | BRANDEIS UNIVERSITY (US) | 2017-10-19 | — | — | WO | disclosed |
| WO-2017105439-A1 | CINCHONINE-DERIVED CATALYSTS AND METHODS OF USING SAME | BRANDEIS UNIVERSITY (US) | 2017-06-22 | — | — | WO | disclosed |
| WO-2016183586-A1 | HIGH MOLECULAR WEIGHT, POST-TRANSLATIONALLY MODIFIED PROTEIN BRUSHES | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2016-11-17 | — | — | WO | disclosed |
| EP-3052486-A1 | INHIBITORS OF BRUTON'S TYROSINE KINASE | Pharmacyclics LLC (US) | 2016-08-10 | — | — | EP | disclosed |
| WO-2016100711-A1 | MODULATORS OF HEPATIC LIPOPROTEIN METABOLISM | THE BROAD INSTITUTE, INC. (US) | 2016-06-23 | — | — | WO | disclosed |
| WO-2015048689-A1 | INHIBITORS OF BRUTON'S TYROSINE KINASE | PHARMACYCLICS, INC. (US) | 2015-04-02 | — | — | WO | disclosed |
| WO-2014143659-A1 | IRREVERSIBLE COVALENT INHIBITORS OF THE GTPASE K-RAS G12C | ARAXES PHARMA LLC (US) | 2014-09-18 | — | — | WO | disclosed |
| EP-2078010-A2 | POLYCYCLIC HETEROARYL SUBSTITUTED TRIAZOLES USEFUL AS AXL INHIBITORS | Rigel Pharmaceuticals, Inc. (US) | 2009-07-15 | — | — | EP | disclosed |
| WO-2008083367-A2 | POLYCYCLIC HETEROARYL SUBSTITUTED TRIAZOLES USEFUL AS AXL INHIBITORS | RIGEL PHARMACEUTICALS, INC. (US) | 2008-07-10 | — | — | WO | disclosed |